Delivery Order SPE2DB25D3404-SPE2DB25FUQMR
- Not listed
- The Defense Logistics Agency awarded a $6,014.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $6,378.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. This non-set-aside, firm fixed-price contract is scheduled for completion by June 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INFUVITE ADULT VIAL 10ML, an intravenous nutritional supplement product, valued at $11.5K. This non-competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $6,017.91 to AmerisourceBergen Drug Corp for Infuvite Adult Vial 10ML, a parenteral nutrition product used in clinical and military healthcare settings. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of August 26, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,460.20 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product. The award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract falling under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,300.14 to AmerisourceBergen Drug Corp for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and operates under firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,620.21 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitively awarded, firm fixed price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Infuvite Pediatric Bulk Vial 50ML, a pediatric parenteral nutrition product. The delivery order, valued at $3,244.45, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQMRDelivery Order
The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a comprehensive global pharmaceutical support vehicle, this IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical commodities such as specialty medications, vaccines, and medical devices. The current delivery order for Infuvite reflects the company's ongoing role as a key pharmaceutical distributor supporting Defense Health Agency and other federal healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/18/25 |